0001907223
Company
Greenland Mines Ltd
Biological Products, (No Diagnostic Substances) · GRML
follow-on
trading
priced
Nasdaq
424B3
Filing Timeline
SEC EDGAR
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2026-02-24 · 0001213900-26-019509
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1 and marks the registration effective.
2025-12-12 · 9999999995-25-003720
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
Price $0.43 · 35,000,000 shares · Gross proceeds $0.00
Common Stock · Exchange NASDAQ · Ticker KLTO · Selling stockholders only · Use of proceeds All net proceeds from the sale of the common shares covered by this prospectus will go to the Selling Stockholders
2025-12-05 · 0001213900-25-118825
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B5 and confirms the priced prospectus.
6,745,000 shares
Common Stock of Klotho Neurosciences, Inc. · Exchange Nasdaq · Ticker KLTO · Selling stockholders only · Use of proceeds To pay certain expenses associated with the sale of Common Shares by the selling shareholders
2025-09-30 · 0001213900-25-093911
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2025-07-28 · 0001213900-25-068145
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2025-07-28 · 0001213900-25-068197
424B5
priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
Gross proceeds $50,000,000
Shares of Common Stock · Exchange Nasdaq · Ticker KLTO · Use of proceeds General corporate purposes · Underwriters A.G.P./Alliance Global Partners
2025-07-28 · 0001213900-25-068301
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2025-07-25 · 9999999995-25-002358
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2025-02-13 · 0001213900-25-013279
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1 and marks the registration effective.
2025-02-10 · 9999999995-25-000375
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
2025-01-30 · 0001213900-25-008318
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2024-10-01 · 0001213900-24-084044
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2024-09-18 · 9999999995-24-002886
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2024-09-13 · 0001213900-24-078244
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 425 in the pre-IPO sequence.
2024-09-05 · 0001213900-24-075939
425
supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2024-06-20 · 0001213900-24-054158
425
supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2024-06-14 · 0001213900-24-052620
425
supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2024-06-14 · 0001213900-24-052956
425
supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2024-05-10 · 0001213900-24-041423
425
supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2024-04-18 · 0001213900-24-034185
425
supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2024-04-12 · 0001213900-24-032343
425
supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2024-04-08 · 0001213900-24-030891
425
supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2024-03-22 · 0001213900-24-025227
425
supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 424B3 in the pre-IPO sequence.
2024-03-11 · 0001213900-24-021257
424B3
priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2024-02-16 · 0001213900-24-014957
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-4/A and marks the registration effective.
2024-02-14 · 9999999995-24-000450
S-4/A
amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior S-4/A filing.
Common Stock · Exchange NASDAQ · Use of proceeds None, as the merger consideration is shares exchanged with ANEW stockholders
2024-02-13 · 0001213900-24-013467
S-4/A
amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior S-4/A filing.
2024-02-12 · 0001213900-24-012321
S-4/A
amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior S-4/A filing.
2024-02-07 · 0001213900-24-010666
S-4/A
amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior S-4/A filing.
2024-02-01 · 0001213900-24-009115
S-4/A
amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior S-4/A filing.
2024-01-03 · 0001213900-24-000608
S-4/A
amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior S-4/A filing.
2023-12-04 · 0001213900-23-092742
S-4/A
amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior 425 filing.
2023-11-08 · 0001213900-23-084599
425
supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-4/A in the pre-IPO sequence.
2023-11-07 · 0001213900-23-084121
S-4/A
amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior 425 filing.
Price $10.00 · 6,000,000 shares
Common · Exchange NASDAQ · Use of proceeds Acquisition of ANEW Medical, Inc. through stock exchange
2023-10-17 · 0001013762-23-004459
425
supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-4 in the pre-IPO sequence.
Redwoods Acquisition Corp. filed a Form 8-K to disclose details of its business combination with ANEW Medical, Inc., including the merger structure, name change to ANEW Medical, Inc., and shareholder voting requirements. The filing includes an investor presentation and forward-looking statements about the transaction's benefits and risks.
2023-08-11 · 0001213900-23-066190
S-4
filed
S-4
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
Common · Exchange NASDAQ · Use of proceeds Acquisition of Anew Medical, Inc. through share exchange
Redwoods Acquisition Corp. filed an S-4 registration statement to effect a business combination with Anew Medical, Inc., resulting in Redwoods changing its name to Anew Medical, Inc. The transaction involves exchanging Anew Medical shares for Redwoods common stock, with contingent consideration shares tied to future stock price milestones. Shareholders will vote on proposals including the merger, charter amendments, and governance changes. The filing also outlines redemption rights for public shareholders and details the combined company's post-merger listing on Nasdaq.
2023-08-04 · 0001213900-23-063756
425
supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
Redwoods Acquisition Corp. (RWOD) has entered into a definitive merger agreement with ANEW Medical, Inc. (LEAS), a biotechnology company developing gene therapies for neurodegenerative diseases. The combined company's pro forma enterprise value is up to $94 million, with $54 million in trust cash. Proceeds will fund ANEW's gene therapy programs for ALS, Alzheimer's, and Parkinson's. The transaction requires shareholder approval and other closing conditions.
2023-06-07 · 0001213900-23-046952
425
supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 424B5 in the pre-IPO sequence.
Redwoods Acquisition Corp. announced a business combination agreement with Xin Bo Xing Group Limited, a Chinese-based new materials technology company. The merger is expected to result in Xin Bo Xing's listing on NASDAQ, with participation from private funds in a PIPE investment. Redwoods, a SPAC focused on carbon neutral and energy storage sectors, previously raised $115 million in an IPO.
2022-12-16 · 0001213900-22-080405
424B5
priced
Final prospectus supplement
Prospectus supplement filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
Price $10.00 · 10,000,000 shares · Gross proceeds $100,000,000
Each unit consists of one share of common stock, one redeemable warrant, and one right to receive one-tenth of a share of common stock upon completion of an initial business combination · Exchange Nasdaq · Ticker RWODU · Over-allotment 1,500,000 · One share of common stock, one redeemable warrant, and one right to receive one-tenth of a share of common stock · Each warrant entitles the holder to purchase one share of common stock at $11.50 per share, exercisable 12 months after the closing of this offering and expiring five years after the completion of an initial business combination · Use of proceeds Proceeds will be held in a trust account for public stockholders, with $10.10 per unit including deferred underwriting fees · Underwriters Chardan Capital Markets, LLC
Redwoods Acquisition Corp., a blank check company, is conducting an IPO to raise $100 million through the sale of 10 million units at $10 each. Each unit includes one share of common stock, a redeemable warrant, and a right to receive 1/10 of a share upon a business combination. The company aims to merge with businesses in the carbon neutral and energy storage sectors. Proceeds will be held in a trust account, with underwriters granted a 45-day option to purchase additional units. The filing also details private placements by the sponsor and underwriters, and restrictions on targeting Chinese-based entities due to regulatory uncertainties.
2022-04-01 · 0001213900-22-017327
8-A12B
effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows S-1/A and registers the class of securities for exchange listing.
Redwoods Acquisition Corp. filed an 8-A12B to register securities under Section 12(b) of the Securities Exchange Act, incorporating by reference the S-1/A registration statement. The filing includes units, common stock, warrants, and rights, with details on the offering structure, underwriting terms, and trust account provisions. The company is a blank check entity targeting carbon neutral and energy storage industries.
2022-03-30 · 0001213900-22-016006
CERT
inactive
CERT
Pre-IPO filing captured from the SEC submission timeline.
Follows 8-A12B in the pre-IPO sequence.
The current filing for Greenland Mines Ltd is a CERT form dated 2022-03-30, but the text appears to be corrupted or improperly formatted, containing non-readable characters and incomplete data. The previous filing was an 8-A12B for Redwoods Acquisition Corp., a separate entity, which does not provide direct comparative context for Greenland Mines Ltd.
2022-03-30 · 0001354457-22-000206
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows CERT and marks the registration effective.
The filing confirms the effectiveness of Form S-1 for Redwoods Acquisition Corp., dated March 30, 2022. The document includes standard form data but lacks detailed narrative content about Greenland Mines Ltd. No substantive updates or disclosures are evident from the provided text.
2022-03-30 · 9999999995-22-000776
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
Price $10.00 · 10,000,000 shares · Gross proceeds $100,000,000
Each unit consists of one share of common stock, one redeemable warrant, and one right to receive 1/10 of a share of common stock upon consummation of an initial business combination · Exchange Nasdaq · Ticker RWODU · Over-allotment 1,500,000 · Each unit includes one share of common stock, one redeemable warrant, and one right to receive 1/10 of a share of common stock · Redeemable warrants exercisable at $11.50 per share, exercisable 12 months after initial business combination · Use of proceeds Proceeds will be placed in a trust account pending initial business combination · Flags units · Underwriters Chardan Capital Markets, LLC
Redwoods Acquisition Corp. is a blank check company formed to pursue a business combination in the carbon neutral and energy storage industries. The S-1/A updates the initial public offering details, including revised warrant terms, trust account structure, and underwriting arrangements. The filing emphasizes restrictions on Chinese-based target businesses and highlights risks related to the business combination process.
2022-03-25 · 0001213900-22-015158
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS in the pre-IPO sequence.
Price $10.00 · 10,000,000 shares · Gross proceeds $100,000,000
Units consisting of one share of common stock, one redeemable warrant, and one right to receive one-tenth of a share of common stock · Exchange Nasdaq · Ticker RWODU · Over-allotment 1,500,000 · Each unit includes one share of common stock, one redeemable warrant, and one right to receive one-tenth of a share of common stock · Each warrant entitles the holder to purchase one-half of one share of common stock at $11.50 per whole share · Use of proceeds Proceeds will be used for the trust account, business combination, and offering expenses · Flags units, warrants · Underwriters Chardan Capital Markets, LLC
Redwoods Acquisition Corp. is a blank check company formed to pursue a business combination in the carbon neutral and energy storage industries. The IPO offers 10,000,000 units at $10.00 each, including common stock, warrants, and rights. The company will deposit $10.10 per unit into a trust account, with proceeds used for a merger, acquisition, or similar transaction. It avoids targets in the People’s Republic of China due to regulatory uncertainties.
2022-03-10 · 0001213900-22-011395
DRS
filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
Redwoods Acquisition Corp. is a blank check company aiming to merge with businesses in the carbon neutral and energy storage industries. The filing details an IPO offering 10,000,000 units at $10.00 each, comprising common stock, warrants, and rights. The company plans to use trust account funds for a business combination, with underwriters granted a 45-day over-allotment option. No public market exists for securities, and listing on Nasdaq is pending.
2022-01-31 · 0001213900-22-004493
Comparable Deals
10 comparable deals
Healthcare & BiotechMicro (<$50M)Last 18 months
Only 0 strict matches; expanded to 10 using nearest neighbors.
Showing top 8 by similarity.
Agomab Therapeutics NV
AGMB
same SICrecent IPO
Eikon Therapeutics, Inc.
EIKN
same SICrecent IPO
Aardvark Therapeutics, Inc.
AARD
same SIC grouprecent IPO
Veradermics, Inc
MANE
same SIC grouprecent IPO
Caring Brands, Inc.
CABR
same SIC grouprecent IPO
Evommune, Inc.
EVMN
same SIC grouprecent IPO
Functional Brands Inc.
MEHA
same SIC grouprecent IPO
MapLight Therapeutics, Inc.
MPLT
same SIC grouprecent IPO
Recent News
No recent news stored for this issuer.